Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | NQO1 | P15559 | 2/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 2/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7482429 | 0.79 | CYP2C9 (0.44) | CA1CA9ALDH1A1CYP2C19MAPT | |
| SCHEMBL12379211 | 0.72 | MAPT (0.45) | CA1CA9ALDH1A1MAPTNPSR1 | |
| SCHEMBL24550469 | 0.72 | SLC6A2 (0.50) | ALDH1A1CYP2C19MAPTGAAKMT2A | |
| SCHEMBL1934617 | 0.72 | CYP2C19 (0.48) | ALDH1A1CYP2C19MAPTNPSR1KMT2A | |
| SCHEMBL8627683 | 0.72 | CYP2C19 (0.48) | ALDH1A1CYP2C19MAPTNPSR1KMT2A | |
| SCHEMBL14776314 | 0.69 | ALDH1A1 (0.44) | ALDH1A1GAAKMT2ATDP1LMNA | |
| SCHEMBL28537348 | 0.68 | MAPK1 (0.44) | MAPTNPSR1GAAKMT2ANQO1 | |
| SCHEMBL17530314 | 0.66 | — | — | |
| SCHEMBL11877378 | 0.66 | MIF (0.43) | ALDH1A1CYP2C19MAPTKMT2ATDP1 | |
| SCHEMBL21420998 | 0.66 | IDO1 (0.41) | ALDH1A1GAAKMT2ATDP1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10993917-B2 | Nanocomplex | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-05-04 | — | — | US | disclosed |
| EP-3142705-B1 | POLYMER-FLAVONOID CONJUGATE AND USES THEREOF | AGENCY SCIENCE TECH & RES (SG) | 2020-08-19 | — | — | EP | disclosed |
| EP-2435504-B1 | FLAVONOID HYDROGEL | AGENCY SCIENCE TECH & RES (SG) | 2020-03-11 | — | — | EP | disclosed |
| US-10406175-B2 | Polymer-flavonoid conjugate and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-09-10 | — | — | US | disclosed |
| US-20190262271-A1 | A NANOCOMPLEX | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-08-29 | — | — | US | disclosed |
| US-10221253-B2 | Phase separated composite | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-03-05 | — | — | US | disclosed |
| WO-2018124970-A1 | A NANOCOMPLEX | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-07-05 | — | — | WO | disclosed |
| US-20170258757-A1 | ANTI-CANCER AGENT DELIVERY VEHICLES CAPABLE OF IMPROVED LOADING | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-09-14 | — | — | US | disclosed |
| US-20170216446-A1 | POLYMER-FLAVONOID CONJUGATE AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-08-03 | — | — | US | disclosed |
| US-9687464-B2 | Anti-cancer agent delivery vehicles capable of improved loading | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-06-27 | — | — | US | disclosed |
| WO-2011019323-A1 | PARTICULATE HYALURONIC ACID FORMULATIONS FOR CELLULAR DELIVERY OF BIOACTIVE AGENTS | AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH (SG) | 2011-02-17 | — | — | WO | disclosed |
| US-7858080-B2 | Aldehyde conjugated flavonoid preparations | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-12-28 | — | — | US | disclosed |
| WO-2010138082-A1 | FLAVONOID HYDROGEL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-12-02 | — | — | WO | disclosed |
| EP-2214715-A1 | METHOD OF DELIVERING AN ANTI-CANCER AGENT TO A CELL | Agency for Science, Technology And Research (SG) | 2010-08-11 | — | — | EP | disclosed |
| US-20100075926-A1 | ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-03-25 | — | — | US | disclosed |
| WO-2010011318-A2 | ACTIVATIQN OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-01-28 | — | — | WO | disclosed |
| WO-2009054813-A1 | METHOD OF DELIVERING AN ANTI-CANCER AGENT TO A CELL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-04-30 | — | — | WO | disclosed |
| US-20080102052-A1 | ALDEHYDE CONJUGATED FLAVONOID PREPARATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH | 2008-05-01 | — | — | US | disclosed |
| EP-1888651-A1 | ALDEHYDE CONJUGATED FLAVONOID PREPARATIONS | Agency for Science, Technology and Research (SG) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006124000-A1 | ALDEHYDE CONJUGATED FLAVONOID PREPARATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221253-B2 | Phase separated composite | COL2A1, COL1A1, COL14A1 | CA1 1073/4885CA9 1136/4885ALDH1A1 213/4885 |
| US-10993917-B2 | Nanocomplex | CD44, PROC, MUC1 | CA1 390/4885CA9 48/4885ALDH1A1 678/4885 |
| US-20170216446-A1 | POLYMER-FLAVONOID CONJUGATE AND USES THEREOF | SYVN1, SELP, PCSK6 | CA1 4229/4885CA9 2742/4885ALDH1A1 2541/4885 |
| US-20100075926-A1 | ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL | GRIK5, HDAC11, GRIK1 | CA1 159/4885CA9 1651/4885ALDH1A1 2825/4885 |
| US-10406175-B2 | Polymer-flavonoid conjugate and uses thereof | SYVN1, SELP, PCSK6 | CA1 4229/4885CA9 2742/4885ALDH1A1 2541/4885 |
| US-20190262271-A1 | A NANOCOMPLEX | CD44, MUC1, PROC | CA1 385/4885CA9 59/4885ALDH1A1 610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.